X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Guest Post: Epilepsy Foundation on rare diseases

By Guest Contributor  |    March 1, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

How innovative medicines are benefiting countries across the globe

By Mark Grayson  |    March 1, 2017
It is important to look at costs across health care systems to fully understand how life-changing medicines are providing a more sustainable path forward. Across the globe, medicines are allowing...   Read More

Why drug importation threatens patient safety

By Allyson Funk  |    February 28, 2017
Counterfeit drug manufacturing and trafficking is a multi-billion dollar business. Legislative proposals to allow importation of potentially counterfeit and substandard drugs into the United...   Read More

Rare Disease Day: Accelerating innovation for patients in need

By Anne McDonald Pritchett, PhD  |    February 28, 2017
As we celebrate Rare Disease Day, it is important to not only reflect on how far we have come in tackling these devastating and complex conditions, but how much unmet medical remains. While more...   Read More

Medicare Monday: There’s an agency called MedPAC?

By Nicole Longo  |    February 27, 2017
Now that we’ve learned more about IPAB and CMMI, there’s one more agency on our list to read up on this month – the Medicare Payment Advisory Commission (MedPAC).   Read More

Fact Check Friday: The truth about drug importation and patient safety

By Allyson Funk  |    February 24, 2017
This week on Fact Check Friday, we’re discussing the truth about proposals to allow the importation of medicines from other countries and what these proposals mean for patients. MYTH: Importation...   Read More

How do multiple sclerosis patients define value?

By Lauren Neves  |    February 24, 2017
There are crucial conversations occurring in the health care system about how value is defined. To explore how multiple sclerosis (MS) patients, providers and payers view value, Real Endpoints...   Read More

PPA: 2016 in review

By Hannah Mooney  |    February 23, 2017
More than a decade has passed since the Partnership for Prescription Assistance (PPA) launched. In this time, PPA has helped nearly 10 million patients through its free and confidential program,...   Read More

ICYMI: New era of medicine initiative kicks off in Boston

By Andrew Powaleny  |    February 22, 2017
It’s no secret that Boston, Massachusetts is home to many of the most groundbreaking advancements in medical discovery. That’s why yesterday, PhRMA sponsored its first national health care...   Read More

Exploring the new era of medicine

By Bill Chin, M.D.  |    February 21, 2017
We are in a new era of medicine where innovations are transforming our ability to attack the cause of disease, not just the symptoms. Where treatment decisions are increasingly focused on the...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates